BioHui Biopharmaceutical

BioHui Biopharmaceutical is a clinical-stage biotechnology company based in Suzhou, China, specializing in the development of innovative biologics for autoimmune and inflammatory diseases. The company focuses on high-demand therapeutic areas including dermatology, rheumatology, and respiratory medicine, with a pipeline centered on monoclonal and bispecific antibodies. Its lead programs target well-validated pathways such as IL-17A and IL-4Rα to treat conditions like psoriasis and atopic dermatitis. BioHui leverages its internal R&D capabilities to advance candidates from discovery through clinical proof-of-concept, aiming to provide more effective and affordable treatment options for patients globally.